- Home
- EYEN
EYEN
Eyenovia Inc.
as 12-18-2024 1:36pm EST
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 9.2M | IPO Year: | 2018 |
| Target Price: | $2.00 | AVG Volume (30 days): | 18.9M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.08 - $2.57 | Next Earning Date: | 11-12-2024 |
| Revenue: | $31,832 | Revenue Growth: | 2557.10% |
| Revenue Growth (this year): | 23413.6% | Revenue Growth (next year): | 400.98% |
Latest Eyenovia Inc. News
EYEN Breaking Stock News: Dive into EYEN Ticker-Specific Updates for Smart Investing
MT Newswires
12 days ago
Eyenovia Signs $1.9 Million Registered Direct Offering
GlobeNewswire
12 days ago
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
GlobeNewswire
23 days ago
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering
TipRanks
25 days ago
Eyenovia taking additional actions to reduce personnel-related costs by over 70%
MT Newswires
a month ago
Sector Update: Health Care Stocks Advance Premarket Friday
MT Newswires
a month ago
Eyenovia Says Avenue Capital Agrees to Potential Loan Restructuring; Shares Up Pre-Bell
GlobeNewswire
a month ago
Eyenovia Provides Update on Restructuring Efforts
MT Newswires
a month ago
Eyenovia Stock Plunges After Firm Reports Potential Restructuring Talks
Compare EYEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EYEN Eyenovia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.